Internet Delivered CBT for Body Dysmorphic Disorder

Conditions

BDD, Body Dysmorphic Disorder

Brief summary

To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.

Oskar Flygare, Erik Andersson, Gjermund Glimsdal, David Mataix‐Cols, Diana Pascal et al. (7 authors)

Internet Interventions2023-01-2510 citations

10.1016/j.invent.2023.100604

Predictors of remission from body dysmorphic disorder after internet-delivered cognitive behavior therapy: a machine learning approach

Oskar Flygare, Jesper Enander, Erik Andersson, Brjánn Ljótsson, Volen Z. Ivanov et al. (7 authors)

BMC Psychiatry2020-05-1943 citations

10.1186/s12888-020-02655-4

Long-term outcome of therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder (BDD-NET): a naturalistic 2-year follow-up after a randomised controlled trial

Jesper Enander, Brjánn Ljótsson, Lina Anderhell, Martin Runeborg, Oskar Flygare et al. (12 authors)

BMJ Open2019-01-0134 citations

10.1136/bmjopen-2018-024307

Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial

Jesper Enander, Erik Andersson, David Mataix‐Cols, Linn Lichtenstein, Katarina Alström et al. (8 authors)

BMJ2016-02-02130 citations

10.1136/bmj.i241

Interventions

BEHAVIORALCognitive behavior therapy

BEHAVIORALSupportive therapy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* outpatient * ≥ 18 years * primary diagnosis of BDD according to the DSM-5 * BDD-YBOCS ≥20 * regular access to a computer with Internet access and skills to use the web.

Exclusion criteria

* psychotropic medication changes within two months prior to the treatment, * completed CBT for BDD within the last 12 months, * other primary axis I diagnosis * current substance dependence * lifetime bipolar disorder or psychosis * suicidal ideation * Axis II diagnosis that could jeopardize treatment participation, * other current psychological treatment that could affect BDD symptoms * A serious medical illness that precludes participation in the study

Design outcomes

Primary

Measure	Time frame
Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS)	Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12)

Secondary

Measure	Time frame
The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S)	Change in MADRS-S from baseline (week 0) to post-treatment (week 12)

Countries

Sweden

Outcome results

None listed